Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29161152 | 0.90 | CYP2A6 (0.31) | CYP2A6 | |
| Chloroform SCHEMBL29264544 | 0.83 | — | — | |
| SCHEMBL22726955 | 0.81 | MAPT (0.40) | CYP2A6 | |
| SCHEMBL12101527 | 0.79 | HTR1B (0.39) | CYP2A6 | |
| SCHEMBL9444609 | 0.79 | CYP2C9 (0.41) | — | |
| SCHEMBL9444538 | 0.79 | CYP2A6 (0.35) | CYP2A6 | |
| SCHEMBL15422818 | 0.76 | ESR1 (0.40) | — | |
| SCHEMBL721815 | 0.76 | ESR1 (0.40) | — | |
| SCHEMBL12763637 | 0.76 | KDM4E (0.49) | — | |
| SCHEMBL246349 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1373246-B1 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | GENEOHM SCIENCES CANADA INC (CA) | 2012-09-12 | — | — | EP | disclosed |
| EP-2404915-A1 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | Infectio Diagnostic (I.D.I.) Inc. (CA) | 2012-01-11 | — | — | EP | disclosed |
| US-7897348-B2 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | GENEOHM SCIENCES CANADA, INC. (CA) | 2011-03-01 | — | — | US | disclosed |
| US-7897348-B2 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | GENEOHM SCIENCES CANADA, INC. (CA) | 2011-03-01 | — | — | US | disclosed |
| US-7897348-B2 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | GENEOHM SCIENCES CANADA, INC. (CA) | 2011-03-01 | — | — | US | disclosed |
| US-20100294723-A1 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | GENOM SCIENCES CANADA INC. (CA) | 2010-11-25 | — | — | US | disclosed |
| US-20100294723-A1 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | GENOM SCIENCES CANADA INC. (CA) | 2010-11-25 | — | — | US | disclosed |
| US-20100294723-A1 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | GENOM SCIENCES CANADA INC. (CA) | 2010-11-25 | — | — | US | disclosed |
| US-20100035272-A1 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | LECLERC MARIO | 2010-02-11 | — | — | US | disclosed |
| US-20100035272-A1 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | LECLERC MARIO | 2010-02-11 | — | — | US | disclosed |
| US-7446213-B2 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | GENEOHM SCIENCES CANADA, INC. (CA) | 2008-11-04 | — | — | US | disclosed |
| US-7083928-B2 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | INFECTIO DIAGNOSTIC (I.D.I.), INC. (CA) | 2006-08-01 | — | — | US | disclosed |
| US-20060160124-A1 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | GENEOHM SCIENCES CANADA INC. (CA) | 2006-07-20 | — | — | US | disclosed |
| US-20040171001-A1 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | GENEOHM SCIENCES CANADA INC. (CA) | 2004-09-02 | — | — | US | disclosed |
| EP-1373246-A2 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | Infectio Diagnostic (I.D.I.) INC. (CA) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002081735-A2 | DETECTION OF NEGATIVELY CHARGED POLYMERS USING WATER-SOLUBLE, CATIONIC, POLYTHIOPHENE DERIVATIVES | INFECTIO DIAGNOSTIC (I.D.I.), INC. (CA) | 2002-10-17 | — | — | WO | disclosed |
| EP-0918766-B1 | SELF-ACID-DOPED HIGHLY CONDUCTING POLYTHIOPHENES | UNIV MONTREAL (CA) | 2002-02-06 | — | — | EP | disclosed |
| US-6051679-A | A META-ALKYLSULFONATE OR META-ALKYLSULFONIC ACID MONOMER CONTAINING POLYTHIOPHENE; POLYMERIZED BY OXIDATIVE DOPING OF THE MONOMER | UNIVERSITEDE MONTREAL (CA) | 2000-04-18 | — | — | US | disclosed |
| EP-0918766-A1 | NOVEL SELF-ACID-DOPED HIGHLY CONDUCTING POLYTHIOPHENES | UNIVERSITE DE MONTREAL (CA) | 1999-06-02 | — | — | EP | disclosed |
| WO-1998003499-A1 | NOVEL SELF-ACID-DOPED HIGHLY CONDUCTING POLYTHIOPHENES | UNIVERSITE DE MONTREAL (CA) | 1998-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160124-A1 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | DNTT, POLRMT, TRDMT1 | CYP2A6 4861/4885 |
| US-20040171001-A1 | Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives | DNTT, POLRMT, NUDT1 | CYP2A6 4846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.